ProMIS to host webinar on Alzheimer's drug trial interim data
Tweet Send to a Friend
ProMIS Neurosciences Inc. (Nasdaq: PMN) announced it will host a webinar on July 28, 2026, to discuss six-month blinded interim ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE


